A drug–drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5‐lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam - Knöchel, Jane; Panduga, Vijender; Nelander, Karin; Heijer, Maria; Lindstedt, Eva‐Lotte; Ali, Hodan; Aurell, Malin; Ödesjö, Helena; Forte, Pablo; Connolly, Kat; Ericsson, Hans; MacPhee, Iain (British journal of clinical pharmacology, 2024)
Keywords: 5‐lipoxygenase activating protein inhibitor; drug–drug interaction; healthy subjects; midazolam; PBPK; pharmacokinetics; PBPK; pharmacokinetics; 5‐lipoxygenase activating protein inhibitor; drug–drug interaction; healthy subjects; midazolam